Archive for October, 2019

Prospective studies reporting associations between cognitive performance and subsequent incident dementia have been subject to attrition bias. Furthermore, the extent to which established risk factors account for such associations requires further elucidation. Read & Research Alzheimer’s More

Be the first to comment

A new study attributes the link between tau protein clumping and brain damage in Alzheimer’s disease to brain immune cells called microglia. Read & Research Alzheimer’s More

Be the first to comment

Acetylcholine is a neurotransmitter that plays a key role in brain and muscle function. Here, we look at what acetylcholine does and describe medical conditions linked with it, including Alzheimer’s and Parkinson’s, and their treatments. Read & Research Alzheimer’s More

Be the first to comment

To determine if sleep-disordered breathing (SDB), daytime sleepiness, insomnia, and sleep duration predict seven-year neurocognitive decline in US Hispanics/Latinos (N = 5247). Read & Research Alzheimer’s More

Be the first to comment

Although the relationship between APOE and Alzheimer’s disease (AD) is well established in populations of European descent, the effects of APOE and ancestry on AD risk in diverse populations is not well understood. Read & Research Alzheimer’s More

Be the first to comment

New research in mice suggests that dabigatran, a blood thinning drug, may help delay the development of Alzheimer’s by maintaining normal brain blood flow. Read & Research Alzheimer’s More

Be the first to comment

We examined the influence of enrollment factors demonstrated to differ by race on incident mild cognitive impairment and dementia using Alzheimer’s Disease Center data. Read & Research Alzheimer’s More

Be the first to comment

Alzheimer’s disease (AD) is a disabling, common cause of dementia, and agitation is one of the most common and distressing symptoms for patients with AD. Escitalopram for agitation in Alzheimer’s disease (S-CitAD) tests a novel, clinically derived therapeutic approach to treat agitation in patients with AD. Read & Research Alzheimer’s More

Be the first to comment

The objective of this study was to assess the usefulness of the appropriate use criteria (AUC) for amyloid imaging in an unselected cohort. Read & Research Alzheimer’s More

Be the first to comment

The aim of this study was to investigate the registry-based national time trends in incidence and prevalence rates of dementia from 1996 to 2015. Read & Research Alzheimer’s More

Be the first to comment

The associations between self-reported current and past leisure time physical activity (LTPA) and Alzheimer’s disease (AD) incidence were determined using data from the multiethnic Washington/Hamilton Heights-Inwood Columbia Aging Project (WHICAP) study. Read & Research Alzheimer’s More

Be the first to comment